title: Direct and indirect effects of insulin on hepatic glucose production in diabetic depancreatized dogs during euglycemia.
abstract: Insulin suppresses glucose production (GP) via both extrahepatic (indirect) and hepatic (direct) effects. We have shown that the direct effect, undetectable in moderately hyperglycemic diabetic dogs, is restored by insulin-induced euglycemia. The first aim of the present study was to determine whether euglycemia per se, and not the excess insulin needed to obtain it, restores the direct effect of insulin on GP. Basal insulin was given portally in depancreatized dogs to attain only moderate hyperglycemia, then an additional insulin was given portally or peripherally to match the peripheral insulin levels and thus to obtain a greater hepatic insulinization with portal delivery. Plasma glucose was allowed to fall to euglycemia before a euglycemic clamp was performed. During euglycemia, there was a tendency (P=0.075) for greater suppression of GP by portal than peripheral insulin. Also, there was a significantly different effect of time (P=0.01) on GP in the two groups, with greater suppression over time in the portal group. The second aim was to test the hypothesis that because of inadequate hepatic insulinization and consequent lack of direct inhibition of GP, peripheral insulin replacement requires peripheral hyperinsulinemia to achieve euglycemia. Portal or peripheral insulin was given to achieve euglycemia and basal GP, and insulin levels were measured. More peripheral insulinemia was required with peripheral than portal insulin replacement to maintain similar euglycemia and GP. Our conclusions are as follows: (1) euglycemia per se is sufficient to acutely restore the direct effect of insulin on GP and (2) at euglycemia, peripheral replacement of insulin, as in insulin-treated diabetes, results in peripheral hyperinsulinemia but unchanged basal GP.
authors.affiliation: Departments of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
authors.forename: Neehar
authors.initials: N
authors.lastname: Gupta
authors.forename: Edward
authors.initials: E
authors.lastname: Park
authors.forename: Harmanjit
authors.initials: H
authors.lastname: Sandhu
authors.forename: Tracy
authors.initials: T
authors.lastname: Goh
authors.forename: Vaja
authors.initials: V
authors.lastname: Tchipashvili
authors.forename: Adria
authors.initials: A
authors.lastname: Giacca
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000378:metabolism*; D004285:Dogs; D005947:Glucose / Q000096:biosynthesis*; D007328:Insulin / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism*; D008102:Liver Circulation; D008297:Male; D023421:Models, Animal; D010180:Pancreatectomy
chemical_list: D001786:Blood Glucose; D007328:Insulin; D005947:Glucose